Your browser doesn't support javascript.
loading
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.
Tan, Wan-Ling; Ng, Quan Sing; Lim, Cindy; Tan, Eng Huat; Toh, Chee Keong; Ang, Mei-Kim; Kanesvaran, Ravindran; Jain, Amit; Tan, Daniel S W; Lim, Darren Wan-Teck.
Affiliation
  • Tan WL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Ng QS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Lim C; Clinical Trials & Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • Tan EH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Toh CK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Ang MK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Jain A; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Lim DW; Genome Institute of Singapore, A*STAR, Singapore, Singapore.
BMC Cancer ; 18(1): 1288, 2018 12 24.
Article in En | MEDLINE | ID: mdl-30583726
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2018 Type: Article